Create Alert
Watchlist

Concord Drugs

₹0.00
0.00 (0.00%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
0.00
Prev. Close
0.00
Volume
NA
Total traded value
NA
Upper Circuit
NA
Lower Circuit
NA

Fundamentals

Market Cap₹70Cr
ROE0.99%
P/E Ratio(TTM)162.79
EPS(TTM)0.43
P/B Ratio2.05
Dividend Yield0.00%
Industry P/E35.04
Book Value34.11
Debt to Equity0.50
Face Value10
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Concord Drugs

Concord Drugs is a pharmaceutical firm, part of a select group in India with an advanced WHO-GMP certified facility for producing high-quality products. The company's management is dedicated to achieving the highest standards of excellence through a system of total quality management in all its operations. Its core strength is providing complete, end-to-end solutions to partners using its Ready-to-Fill Pellets and Finished Pharmaceutical Formulations.;
Parent OrganisationConcord Drugs Limited
Managing DirectorMr. Seelam Reddy
BSE Symbol538965

Shareholding Pattern

Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Promoters
54.39%
Retail And Others
45.61%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Cohance Lifesciences
NA
(0.00%)
113.86
JB Chemicals & Pharmaceuticals
NA
(0.00%)
39.02
Emcure Pharmaceuticals
NA
(0.00%)
35.08
Wockhardt
NA
(0.00%)
-201.86